Global Nosocomial Infections Market

Global Nosocomial Infections Market Size Insights Forecasts to 2035

• The Global Nosocomial Infections Market Size Was valued at USD 4997.9 Million in 2024
• The Global Nosocomial Infections Market Size is Expected to Grow at a CAGR of around 8.23% from 2025 to 2035
• The Worldwide Nosocomial Infections Market Size is Expected to Reach USD 11928.5 Million by 2035
• Asia-Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Decisions Advisors and Consulting, The Global Nosocomial Infections Market Size Was Worth Around USD 4997.9 Million In 2024 And Is Predicted To Grow To Around USD 11928.5 Million By 2035 With A Compound Annual Growth Rate (CAGR) Of 8.23% From 2025 to 2035. Future opportunities include rapid diagnostics adoption and antimicrobial stewardship programs and AI-driven infection surveillance and advanced sterilization technologies and hospital automation and vaccine development and telehealth monitoring and emerging market expansion and public health initiatives and increased demand for infection prevention solutions.

 

Market Overview

The global nosocomial infections market describes the international market which develops methods to stop hospital-acquired infections that patients acquire during their time in healthcare facilities. The disease category includes bloodstream infections and surgical site infections and urinary tract infections and ventilator-associated pneumonia. The market experiences growth because hospitals admit more patients and surgical operations increase and antimicrobial resistance develops. Governments together with public health organizations establish stronger infection control rules while they allocate money for monitoring systems and they support improved hospital cleanliness practices to fight disease spread. The market expands through better rapid testing equipment and sterilization methods and antimicrobial drugs and systems that track infections. Healthcare providers are implementing preventive measures because of awareness campaigns and mandatory reporting requirements which are increasing the demand for infection control products and clinical management solutions throughout the world.

 

Report Coverage

This research report categorizes the nosocomial infections market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the nosocomial infections market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the nosocomial infections market. 

 

Driving Factors

The healthcare system faces increased demand because of three components which include growing hospital admissions and rising surgical interventions and the escalating threat of antimicrobial resistance which makes infections more likely to occur. The demand for products exists because government organizations enforce strict infection-control regulations and hospitals maintain their safety standards. The global adoption of prevention methods and monitoring systems and treatment solutions receives acceleration from innovations which include AI-based infection surveillance and rapid molecular diagnostics and antimicrobial coatings and UV sterilization systems and smart disinfection robots and advanced wound-care technologies.

 

Restraining Factors

The restraining factors exist because advanced infection-control technologies their high costs which exceed current budget limitations in developing regions and hospitals lack essential infrastructure and facilities need more trained staff and the complex nature of antimicrobial resistance together with the strict nature of regulatory approvals and small facilities having low knowledge and medical facilities showing different levels of hygiene and surveillance practices.

 

Market Segmentation

The nosocomial infections market share is classified into products and end users.

 

• The heat sterilization equipment segment dominated the market in 2024, approximately 35% and is projected to grow at a substantial CAGR during the forecast period.

Based on the products, the nosocomial infections market is divided into heat sterilization equipment, low-temperature sterilization equipment, radiation sterilization equipment, and disinfection equipment. Among these, the heat sterilization equipment segment dominated the market in 2024, approximately 35% and is projected to grow at a substantial CAGR during the forecast period. The proven effectiveness and cost-effectiveness of the treatment method combined with its widespread adoption in hospitals and laboratories supports its use. Steam autoclaving methods provide dependable microbial destruction while fulfilling all necessary regulatory standards. The increasing volume of surgical procedures together with strict infection control measures and the long-lasting performance of medical equipment and simple operational processes leads to greater medical facility adoption of these systems in healthcare facilities worldwide.

• The hospitals segment accounted for the largest share in 2024, approximately 45% and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end users, the nosocomial infections market is divided into hospitals, ambulatory surgical centre, medical institutions, diagnostic laboratories, and clinics. Among these, the hospitals segment accounted for the largest share in 2024, approximately 45% and is anticipated to grow at a significant CAGR during the forecast period. The hospital experiences elevated patient admission rates which results in increased surgical operations together with a higher likelihood of patients acquiring infections during their hospital stay. Infection control measures succeed because the hospital possesses strong infection control procedures together with advanced sterilization equipment and their skilled workers and their financial resources. The requirement for infection prevention methods increases through the expansion of intensive care units together with emergency services and government safety regulations.

 

Regional Segment Analysis of the Nosocomial Infections Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)
•  

North America is anticipated to hold the largest share of the nosocomial infections market over the predicted timeframe.

North America is anticipated to hold the largest share of the nosocomial infections market over the predicted timeframe. The existence of advanced hospital infrastructure together with strict infection-control regulations and high healthcare spending and effective reimbursement systems. The regional market dominance is strengthened by the presence of major medical device manufacturers and active surveillance programs and the early adoption of new technologies and increasing surgical procedures and government-led patient safety initiatives.

 

Asia-Pacific is expected to grow at a rapid CAGR in the nosocomial infections market during the forecast period. The rising hospitalization rates together with expanding healthcare infrastructure and increasing surgical procedures and improving infection-control awareness lead to a situation where hospitals face capacity challenges. The regional market experiences accelerated growth because of government healthcare investments and increasing medical tourism and rising healthcare expenditures and expanded diagnostic facilities and growing use of sterilization and disinfection technologies.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the nosocomial infections market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Pfizer Inc.
• Merck & Co., Inc. (MSD)
• Johnson & Johnson (Janssen Pharmaceuticals)
• Novartis AG
• Roche Holding AG
• GlaxoSmithKline plc (GSK)
• Bayer AG
• Abbott Laboratories
• Takeda Pharmaceutical Company Ltd.
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the nosocomial infections market based on the below-mentioned segments: 

 

Global Nosocomial Infections Market, By Products

• Heat Sterilization Equipment
• Low-Temperature Sterilization Equipment
• Radiation Sterilization Equipment
• Disinfection Equipment

 

Global Nosocomial Infections Market, By End Users

• Hospitals
• Ambulatory Surgical Centre
• Medical Institutions
• Diagnostic Laboratories
• Clinics

 

Global Nosocomial Infections Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  •  South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

 

Frequently Asked Questions (FAQ)

 

1. What is the projected growth of the global nosocomial infections market?

A: The market is projected to grow from USD 4,997.9 million in 2024 to USD 11,928.5 million by 2035, registering a CAGR of 8.23% due to rising infection prevention demand.

 

2. Which product segment dominates the market and why?

A: Heat sterilization equipment leads with around 35% share, supported by cost-effectiveness, proven microbial elimination, regulatory compliance, widespread hospital adoption, growing surgical volumes, durable systems, and easy operational processes.

 

3. Which end-user segment holds the largest share?

A: Hospitals dominate with approximately 45% share due to high patient admissions, frequent surgeries, elevated infection risk, strong infection-control protocols, advanced sterilization systems, skilled professionals, and expanding critical care infrastructure.

 

4. Which regions lead market performance?

A: North America leads due to advanced infrastructure, regulations, and spending, while Asia-Pacific grows fastest from expanding healthcare systems, rising hospitalizations, investments, and infection-control adoption.

 

5. What factors are driving market growth?

A: Growth is driven by increasing hospital admissions, rising surgeries, antimicrobial resistance threats, strict infection-control policies, and innovations including AI surveillance, rapid molecular diagnostics, antimicrobial coatings, UV sterilization, disinfection robots, and advanced wound-care technologies.